Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–97.
Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6(5):376–85.
Friedman RC, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92–105.
Article PubMed PubMed Central Google Scholar
MacFarlane L-A, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–61.
Article PubMed PubMed Central Google Scholar
Jansson MD, Lund AH. MicroRNA and cancer. Mol Oncol. 2012;6(6):590–610.
Article PubMed PubMed Central Google Scholar
Mathelier A, Carbone A. Large scale chromosomal mapping of human microRNA structural clusters. Nucleic Acids Res. 2013;41(8):4392–408.
Article PubMed PubMed Central Google Scholar
Lee Y, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425(6956):415–9.
Doerks T, et al. Systematic identification of novel protein domain families associated with nuclear functions. Genome Res. 2002;12(1):47–56.
Article PubMed PubMed Central Google Scholar
Zhang W, et al. miR-33b in human cancer: mechanistic and clinical perspectives. Biomed Pharmacother. 2023;161: 114432.
Li Z, et al. The miR-302/367 cluster: aging, inflammation, and cancer. Cell Biochem Funct. 2023;41(7):752–66.
Bi W, et al. The diagnostic and prognostic role of miR-27a in cancer. Pathol Res Pract. 2023;247: 154544.
Sukmana BI, et al. A thorough and current study of miR-214-related targets in cancer. Pathol Res Pract. 2023;249: 154770.
Li J, et al. Role of miR-21 in the diagnosis of colorectal cancer: meta-analysis and bioinformatics. Pathol Res Pract. 2023;248: 154670.
Ashrafizadeh M, et al. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: role of microRNAs and upstream mediators. Cell Signal. 2021;78: 109871.
Olena AF, Patton JG. Genomic organization of microRNAs. J Cell Physiol. 2010;222(3):540–5.
Article PubMed PubMed Central Google Scholar
Wienholds E, et al. MicroRNA expression in zebrafish embryonic development. Science. 2005;309(5732):310–1.
Ahmed A, et al. A database of microRNA expression patterns in Xenopus laevis. PLoS ONE. 2015;10(10): e0138313.
Article PubMed PubMed Central Google Scholar
Rupaimoole R, et al. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 2016;6(3):235–46.
Article PubMed PubMed Central Google Scholar
Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012;143(3):550–63.
Mehta A, Baltimore D. MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol. 2016;16(5):279–94.
Contreras J, Rao D. MicroRNAs in inflammation and immune responses. Leukemia. 2012;26(3):404–13.
Bai H, Wu S. miR-451: a novel biomarker and potential therapeutic target for cancer. Onco Targets Ther. 2019;12:11069.
Article PubMed PubMed Central Google Scholar
Qin N, et al. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype. Theranostics. 2020;10(24):11264–77.
Article PubMed PubMed Central Google Scholar
Rezaei T, et al. microRNA-181a mediates the chemo-sensitivity of glioblastoma to carmustine and regulates cell proliferation, migration, and apoptosis. Eur J Pharmacol. 2020;888: 173483.
Dastmalchi N, et al. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Life Sci. 2020;259: 118239.
Aslan C, et al. Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs. Life Sci. 2020;258: 118094.
Alizadeh M, et al. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy. J Cell Physiol. 2019;234(11):19280–97.
Xu B, et al. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells. NeuroReport. 2020;31(6):498–506.
Gao A-M, et al. circ_ARF3 regulates the pathogenesis of osteosarcoma by sponging miR-1299 to maintain CDK6 expression. Cell Signal. 2020;72: 109622.
Hu T, et al. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells. J Cell Physiol. 2020;235(11):8319–33.
Wang Q, et al. Regulation of integrin subunit alpha 2 by miR-135b-5p modulates chemoresistance in gastric cancer. Front Oncol. 2020;10:308.
Article PubMed PubMed Central Google Scholar
Meng Q, et al. A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967.
Article PubMed PubMed Central Google Scholar
Huang L, et al. MiR-377-3p suppresses colorectal cancer through negative regulation on Wnt/β-catenin signaling by targeting XIAP and ZEB2. Pharmacol Res. 2020;156: 104774.
Chong ZX, Yeap SK, Ho WY. Regulation of autophagy by microRNAs in human breast cancer. J Biomed Sci. 2021;28(1):21.
Article PubMed PubMed Central Google Scholar
Khandia R, et al. A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease prevention, novel drug design, and therapy. Cells. 2019;8(7):674.
Article PubMed PubMed Central Google Scholar
Gozuacik D, et al. Autophagy-Regulating microRNAs and Cancer. Front Oncol. 2017;7:65.
留言 (0)